Fibrinogen (human) + thrombin (human) (TachoSil)
TC-015-IN
Phase 3 other completed
Quick answer
Fibrinogen (human) + thrombin (human) (TachoSil) for Surgical Resection of Superficial Renal Tumour is a Phase 3 program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Surgical Resection of Superficial Renal Tumour
- Phase
- Phase 3
- Modality
- other
- Status
- completed